# EDGAR Filing Document

**Accession Number:** 0001704287
**File Stem:** 0001213900-26-012963
**Filing Date:** 2026-2
**Character Count:** 10314
**Document Hash:** 4147796551ec306ce417c8a03cf24ada
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-012963.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001213900-26-012963

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bluejay Diagnostics, Inc.
- **CENTRAL INDEX KEY:** 0001704287
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 473552922
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93056
- **FILM NUMBER:** 26604915

**BUSINESS ADDRESS:**
- **STREET 1:** 360 MASSACHUSETTS AVENUE, SUITE 203
- **CITY:** ACTON
- **STATE:** MA
- **ZIP:** 01720
- **BUSINESS PHONE:** (978) 631-0152

**MAIL ADDRESS:**
- **STREET 1:** 360 MASSACHUSETTS AVENUE, SUITE 203
- **CITY:** ACTON
- **STATE:** MA
- **ZIP:** 01720
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NORTHSTRIVE FUND II LP
- **CENTRAL INDEX KEY:** 0002099270

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 120 NEWPORT CENTER DR
- **STREET 2:** STE 250
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 926660
- **BUSINESS PHONE:** 9498757003

**MAIL ADDRESS:**
- **STREET 1:** 120 NEWPORT CENTER DR
- **STREET 2:** STE 250
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 926660

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Bluejay Diagnostics, Inc.

**Title of Class of Securities:** Common Stock, $0.0001 par value per share

**CUSIP Number:** 095633608

**Date of Event Which Requires Filing of this Statement:** 02/05/2026

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [x] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Northstrive Fund II LP | Names of Reporting Persons<br>Northstrive Fund II LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>11000.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>11000.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>11000.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>11000.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>1.55% | Percent of Class Represented by Amount in Row (9)<br>1.55% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 11,000 shares of Bluejay Diagnostics, Inc. ("Issuer") beneficially owned by Northstrive Fund II LP, out of 708,533 shares of the Issuer's issued and outstanding shares of common stock, par value $0.0001 per share ("Common Stock") on January 29, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission ("Commission") on January 27, 2026.

---

| 1. | Names of Reporting Persons<br>Braeden Lichti | Names of Reporting Persons<br>Braeden Lichti |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>Z4 | Citizenship or Place of Organization<br>Z4 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>24500.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>11000.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>24500.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>11000.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>35500.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>35500.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.01% | Percent of Class Represented by Amount in Row (9)<br>5.01% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 35,500 shares of Issuer beneficially owned by Mr. Lichti, out of 708,533 shares of the Issuer's issued and outstanding shares of Common Stock on January 29, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the Commission on January 27, 2026.

---

**Item 1(a). Name of Issuer:**
Bluejay Diagnostics, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
360 Massachusetts Avenue, Suite 203, Action, MA 01720

**Item 2(a). Name of Person Filing:**
This statement is filed by:

(i) Northstrive Fund II LP, a Delaware limited partnership; and

(ii) Braeden Lichti ("Mr. Lichti").

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."

**Item 2(b). Address of Principal Business Office:**
120 Newport Center Drive, Suite 250
Newport Beach, CA 92660

**Item 2(c). Citizenship:**
Northstrive Fund II LP is a Delaware corporation. Mr. Lichti is a citizen of Canada.

**Item 2(d). Title of Class of Securities:**
Common Stock, $0.0001 par value per share

**Item 2(e). CUSIP Number:**
095633608

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

The information required by Item 4(a) is set forth in Rows 5-11 of the cover page for each Reporting Person and is incorporated herein by reference for each Reporting Person.

**(b) Percent of class:**

Northstrive Fund II LP: 1.55%
Braeden Lichti: 5.01%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

Northstrive Fund II LP: 0
Braeden Lichti: 24,500

**(ii) Shared power to vote or to direct the vote:**

Northstrive Fund II LP: 11,000
Braeden Lichti: 11,000

**(iii) Sole power to dispose or to direct the disposition of:**

Northstrive Fund II LP: 0
Braeden Lichti: 24,500

**(iv) Shared power to dispose or to direct the disposition of:**

Northstrive Fund II LP: 11,000
Braeden Lichti: 11,000

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Northstrive Fund II LP**

**Date:** 02/05/2026

**By:** /s/ Braeden Lichti

**Name & Title:** Braeden Lichti, Manager

**Braeden Lichti**

**Date:** 02/05/2026

**By:** /s/ Braeden Lichti

**Name & Title:** Braeden Lichti